SNDL Inc. Files August 2024 Report on Form 6-K

Ticker: SNDL · Form: 6-K · Filed: 2024-08-13T00:00:00.000Z

Sentiment: neutral

Topics: filing, 6-K, news-release

TL;DR

SNDL filed its August 6-K, including a news release. Check for updates.

AI Summary

SNDL Inc. filed a Form 6-K on August 13, 2024, reporting for the month of August 2024. The filing includes a news release dated August 13, 2024, as Exhibit 99.1. The company, formerly known as Sundial Growers Inc., is incorporated in Alberta, Canada, and operates in the medicinal chemicals and botanical products sector.

Why It Matters

This filing provides an update on the company's activities and financial reporting, which is crucial for investors to stay informed about its current status and any material developments.

Risk Assessment

Risk Level: low — This is a routine filing (Form 6-K) that primarily serves as an update and does not appear to contain significant new financial or operational disclosures that would immediately alter risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing by SNDL Inc.?

The Form 6-K is a report of a foreign private issuer filed for the month of August 2024, and it includes a news release dated August 13, 2024, as an exhibit.

When was the news release included in this filing dated?

The news release, Exhibit 99.1, is dated August 13, 2024.

What was SNDL Inc.'s former name?

SNDL Inc.'s former name was Sundial Growers Inc., with a date of name change on January 31, 2019.

Who signed this Form 6-K on behalf of SNDL Inc.?

The Form 6-K was signed by Alberto Paredero Quiros, Chief Financial Officer.

What is SNDL Inc.'s principal executive office address?

SNDL Inc.'s principal executive offices are located at #300, 919 - 11 Avenue SW, Calgary, AB T2R 1P3.

From the Filing

0001279569-24-001019.txt : 20240813 0001279569-24-001019.hdr.sgml : 20240813 20240813084158 ACCESSION NUMBER: 0001279569-24-001019 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240813 FILED AS OF DATE: 20240813 DATE AS OF CHANGE: 20240813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SNDL Inc. CENTRAL INDEX KEY: 0001766600 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39005 FILM NUMBER: 241198958 BUSINESS ADDRESS: STREET 1: 919 11 AVENUE SW STREET 2: SUITE 300 CITY: CALGARY STATE: A0 ZIP: T2R1P3 BUSINESS PHONE: 14039485227 MAIL ADDRESS: STREET 1: 919 11 AVENUE SW STREET 2: SUITE 300 CITY: CALGARY STATE: A0 ZIP: T2R1P3 FORMER COMPANY: FORMER CONFORMED NAME: Sundial Growers Inc. DATE OF NAME CHANGE: 20190131 6-K 1 sndl6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number 001-39005 SNDL INC. (Registrant’s name) #300, 919 - 11 Avenue SW Calgary, AB T2R 1P3 Tel.: (403) 948-5227 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☐ Form 40-F ☒ SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SNDL INC. Date: August 13, 2024 By: /s/ Alberto Paredero Quiros Name: Alberto Paredero Quiros Title: Chief Financial Officer EXHIBIT Exhibit Description of Exhibit 99.1 News Release dated August 13, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED AUGUST 13, 2024 Exhibit 99.1 SNDL to Acquire Remaining Minority Interest of Nova Cannabis SNDL and Nova Execute Arrangement Agreement with Key Shareholder Support CALGARY, AB, Aug. 13, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) (" SNDL ") and Nova Cannabis Inc. (TSX: NOVC) (" Nova ") are pleased to announce that they have entered into an arrangement agreement (the " Agreement ") pursuant to which SNDL will acquire all of the issued and outstanding common shares in the capital of Nova (" Nova Shares ") not already owned by SNDL, representing approximately 34.8% of Nova Shares, by way of a statutory plan of arrangement (the " Transaction ") for aggregate consideration of approximately $40 million (the " Consideration "). All financial information in this press release is reported in Canadian dollars unless otherwise indicated. "Today's announcement by our Alberta-based corporations underscores our commitment to sustainable performance in Canadian cannabis," said Zach George, SNDL's Chief Executive Officer. "We are committed to building a consumer-centric model at scale, supported by SNDL's robust shared service model, access to capital, and a well-developed cannabis retail pipeline. These factors are integral to the achievement of sustained profitable growth." Transaction Benefits Retail Expertise: Nova's retail expertise will support SNDL's entire cannabis retail portfolio to enhance programming, expand data programs, advance staff training initiatives, and optimize inventory management. Synergies and Cost Rationalization: The Transaction is anticipated to generate savings through the streamlining of public company expenses and the optimization of general and administrative costs. Access to Capital: SNDL's robust balance sheet will ensure that Nova's retail platform continues to be supported in a competitive and challenging environment. "The proposed Transaction offers liquidity and certainty to minority sha

View on Read The Filing